Vertex Revenue and Competitors
Estimated Revenue & Valuation
- Vertex's estimated annual revenue is currently $306.7M per year.
- Vertex's estimated revenue per employee is $203,000
Employee Data
- Vertex has 1511 Employees.
Vertex's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Strategy Officer (CSO) | Reveal Email/Phone |
2 | Chief Economist & Senior Tax Policy Director | Reveal Email/Phone |
3 | Chief Accounting Officer (CAO) | Reveal Email/Phone |
4 | Chief Accounting Officer | Reveal Email/Phone |
5 | VP Indirect Tax Solutions Line Business | Reveal Email/Phone |
6 | VP, Revenue Operations and Enablement | Reveal Email/Phone |
7 | VP SAP Business Development | Reveal Email/Phone |
8 | VP Technology Strategy | Reveal Email/Phone |
9 | Head European Marketing | Reveal Email/Phone |
10 | VP Global Channel Sales at Vertex Inc. | Reveal Email/Phone |
Vertex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.3M | 34 | N/A | N/A | N/A |
#2 | $195M | 4733 | 4% | $341M | $9.5B |
#3 | $0.1M | 1 | 0% | N/A | N/A |
#4 | $475M | 2600 | 0% | N/A | N/A |
#5 | $4330M | 17841 | N/A | N/A | $45.1B |
#6 | $3785.7M | 18649 | N/A | N/A | N/A |
#7 | $70.7M | 404 | N/A | N/A | N/A |
#8 | $509.9M | 2743 | 0% | $746.1M | $10B |
#9 | $13.6M | 97 | 4% | $91.8M | N/A |
#10 | $26.3M | 131 | N/A | N/A | N/A |
#11 | $406.1M | 1873 | -2% | $220M | $5.2B |
#12 | $107.7M | 606 | 3% | $229.9M | $1.2B |
#13 | $99.6M | 541 | 3% | $7.5M | N/A |
#14 | $308.5M | 2992 | 5% | $279.7M | $18.6B |
#15 | $6.7M | 51 | N/A | N/A | N/A |
#16 | $0.9M | 7 | N/A | N/A | N/A |
#17 | $36M | 234 | N/A | N/A | N/A |
#18 | $16.1M | 111 | N/A | N/A | N/A |
#19 | $12.9M | 99 | -9% | $24.9M | N/A |
#20 | $0.8M | 8 | N/A | N/A | N/A |
What Is Vertex?
N/A
Total Funding
1511
Number of Employees
$306.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vertex News
2022-04-19 - The Zacks Analyst Blog Highlights Johnson & Johnson, Eli Lilly, Vertex
Pharmaceuticals and Deciphera Pharmaceuticals
Stocks recently featured in the blog include: Johnson & Johnson JNJ, Eli Lilly LLY, Vertex Pharmaceuticals VRTX and Deciphera...
2022-04-17 - Health Canada approves Vertex's Trikafta for cystic fibrosis in ...
Vertex's Trikafta was found to be well-tolerated in a Phase III trial in CF patients aged six to 11 years. Credit: Vertex Pharmaceuticals...
2022-04-06 - Vertex CEO Kewalramani nabs more than $15M in 2021 pay ...
In her first full year at the top of cystic fibrosis juggernaut Vertex Pharmaceuticals, CEO Reshma Kewalramani has collected a pay package that rivals...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $332.9M | 1656 | 19% | N/A |
#2 | $531.6M | 1726 | N/A | N/A |
#3 | $776.4M | 2054 | 4% | N/A |
#4 | $895.9M | 2370 | 6% | N/A |
#5 | $634.2M | 3124 | N/A | N/A |